Among cardiovascular patients with angina or heart failure, the UGT1A1*6/*6 genotype had a lower capacity to glucuronidate the beta-blocker carvedilol compared with patients with the wild-type UGT1A1*1/*1 genotype [78]. Here, UGT1A1 is linked to angina pectoris.